Showing results (61-70 of 102) with videos related to
Sort By:
Pageof 11
American Journal of Epidemiology|November 5, 2016
Peripheral Arterial Disease and Its Association With Arsenic Exposure and Metabolism in the Strong Heart StudyJonathan D Newman, Ana Navas-Acien, Chin-Chi Kuo, et al.Arteriosclerosis, Thrombosis, and Vascular Biology|December 7, 2023
Platelet RNA Biomarker of Ticagrelor-Responsive Genes Is Associated With Platelet Function and Cardiovascular EventsRachel A Myers, Thomas L Ortel, Alexander Waldrop, et al.Journal of Hypertension|July 4, 2014
The effect of hormone therapy on mean blood pressure and visit-to-visit blood pressure variability in postmenopausal women: results from the Women's Health Initiative randomized controlled trialsDaichi Shimbo, Lu Wang, Michael J Lamonte, et al.Journal of the American College of Cardiology|August 18, 2022
Association of Medication Adherence With Health Outcomes in the ISCHEMIA TrialR Angel Garcia, John A Spertus, Mary C Benton, et al.Nature Communications|June 16, 2026
Whole blood epigenomic and transcriptomic characterization identifies vulnerable molecular subtypes of chronic coronary diseaseMatthew Muller, MacIntosh G Cornwell, Sandhya Rajkumar, et al.Journal of the American College of Cardiology|April 10, 2024
Variation in Health Status With Invasive vs Conservative Management of Chronic Coronary DiseaseSuzanne V Arnold, Philip G Jones, David J Maron, et al.Journal of Clinical Lipidology|January 19, 2025
Variation in lipoprotein(a) response to potent lipid lowering: The role of apolipoprotein (a) isoform sizeAdedoyin Akinlonu, Michael B Boffa, Chen Lyu, et al.The American Journal of Medicine|October 22, 2013
Does CHA2DS2-VASc improve stroke risk stratification in postmenopausal women with atrial fibrillation?Joellyn M Abraham, Joseph Larson, Mina K Chung, et al.American Heart Journal|August 21, 2023
Biomarkers and cardiovascular events in patients with stable coronary disease in the ISCHEMIA TrialsJonathan D Newman, Rebecca Anthopolos, Kelly V Ruggles, et al.Journal of the American Heart Association|May 22, 2025
Association of Lipoprotein(a) With Major Adverse Limb Events and All-Cause Mortality Following Revascularization for Chronic Limb-Threatening Ischemia: A Substudy of the BEST-CLI TrialAlexander E Sullivan, Shi Huang, Suman Kundu, et al.Pageof 11